Inventor · disambiguated record
Cristobal Alhambra
Also filed as: ALHAMBRA CRISTOBAL
3 granted patents·10 pending applications·6 citations·filing 2006–2010
60Inventor score
Technology areasA61P
Top patents by PatentIndex Score
13 records- 0173US8071621B2Alkylsulphonamide quinolinesSIMPSON THOMAS·Filed 2009·Granted Dec 6, 2011·4 cites·4 claims
- 0269US7964733B2Alkyl sulfoxide quinolines as NK-3 receptor ligandsASTRAZENECA AB·Filed 2006·Granted Jun 21, 2011·1 cites·8 claims
- 0368US7608628B2Alkylsulphonamide quinolinesASTRAZENECA AB·Filed 2006·Granted Oct 27, 2009·1 cites·2 claims
- 0445US2009030033A1Novel Compounds 894ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0542US2009054445A1Amide Substituted QuinolinesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0642US2008234269A1N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor LigandsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 0741US2008306110A1Alkylnitrile Quinolines as Nk-3 Receptor LigandsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 0841US2008200500A1Quinoline Derivatives as Nk3 AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 0941US2008200504A1Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1041US2008287492A1Alkylpyridyl Quinolines as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1141US2008280949A1Oxopyridyl Quinoline Amides as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1241US2008194622A1Quinoline 3-Sulfonate Esters as Nk3 Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1331US2012094995A12-aza-bicyclo[2.2.1]heptane compounds and uses thereofALBERT JEFFREY SCOTT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cristobal Alhambra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →